Wall Street analysts expect Lannett Company, Inc. (NYSE:LCI) to post $128.63 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Lannett’s earnings, with the highest sales estimate coming in at $130.50 million and the lowest estimate coming in at $127.60 million. Lannett posted sales of $193.72 million in the same quarter last year, which suggests a negative year over year growth rate of 33.6%. The firm is scheduled to issue its next earnings report on Wednesday, February 5th.
According to Zacks, analysts expect that Lannett will report full-year sales of $537.39 million for the current financial year, with estimates ranging from $535.07 million to $539.60 million. For the next year, analysts anticipate that the company will post sales of $588.78 million, with estimates ranging from $572.50 million to $615.14 million. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Lannett.
Lannett (NYSE:LCI) last released its earnings results on Wednesday, November 6th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.03. The firm had revenue of $127.30 million for the quarter, compared to analyst estimates of $120.78 million. Lannett had a return on equity of 25.40% and a net margin of 0.52%. The company’s quarterly revenue was down 17.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.44 earnings per share.
In other Lannett news, Director Albert Paonessa III sold 16,195 shares of Lannett stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $12.54, for a total transaction of $203,085.30. Following the transaction, the director now directly owns 45,945 shares in the company, valued at $576,150.30. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 12.57% of the company’s stock.
Several institutional investors have recently made changes to their positions in LCI. Metropolitan Life Insurance Co NY bought a new position in shares of Lannett during the 1st quarter valued at about $77,000. Commonwealth Equity Services LLC lifted its stake in Lannett by 159.9% in the second quarter. Commonwealth Equity Services LLC now owns 26,293 shares of the company’s stock valued at $159,000 after buying an additional 16,175 shares in the last quarter. AE Wealth Management LLC lifted its stake in Lannett by 160.9% in the second quarter. AE Wealth Management LLC now owns 62,193 shares of the company’s stock valued at $377,000 after buying an additional 38,356 shares in the last quarter. Strs Ohio bought a new position in Lannett in the second quarter valued at approximately $603,000. Finally, Dupont Capital Management Corp boosted its holdings in shares of Lannett by 67.2% in the second quarter. Dupont Capital Management Corp now owns 63,975 shares of the company’s stock valued at $388,000 after buying an additional 25,716 shares during the period.
Shares of LCI stock traded up $0.31 on Monday, reaching $8.80. The company had a trading volume of 1,090,258 shares, compared to its average volume of 1,552,192. The stock has a market cap of $354.95 million, a PE ratio of 3.74 and a beta of 2.16. The company has a 50-day moving average of $10.25 and a 200-day moving average of $8.54. The company has a current ratio of 2.43, a quick ratio of 1.60 and a debt-to-equity ratio of 2.07. Lannett has a 12 month low of $4.33 and a 12 month high of $15.52.
Lannett Company Profile
Lannett Company, Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages.
Further Reading: What is cost of equity?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Lannett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett and related companies with MarketBeat.com's FREE daily email newsletter.